Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Colgate mouth rinses for SARS-CoV-2 inactivation
NCT04748783Phase 2Terminated
- Sponsor
- University of North Carolina at Chapel Hill
- Start
- Mar 2021
- Primary completion
- Apr 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of hydrogen peroxide, chlorhexidine, Colgate Zero in coronavirus disease 2019 (COVID-19), sponsored by University of North Carolina at Chapel Hill. Started Mar 2021; status: terminated.
02
Drugs
hydrogen peroxidechlorhexidineColgate Zero
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on NCT04748783.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04748783.